| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |